摘要
目的探讨口服茵栀黄联合妈咪爱治疗新生儿黄疸的临床效果。方法选取2014年11月—2015年11月来该院接受治疗的180例新生儿黄疸患儿为研究对象,随机将其均分为对照组和观察组各90例,其中对照组接受常规疗法,观察组在蓝光照射下,接受口服茵栀黄、妈咪爱联合疗法。治疗后,比较两组的临床效果及黄疸持续时间。结果临床效果：观察组的总有效率为93.3%（84/90）,对照组的总有效率为66.7%（60/90）,观察组的总有效率高于对照组（P〈0.05,χ~2=20.0）;观察组的黄疸持续时间为（4.6±1.0）d,明显短于对照组（6.9±1.4）d,二者差异有统计学意义（P〈0.01,t=12.6）。结论针对新生儿黄疸,临床上应主张选择蓝光照射加口服茵栀黄、妈咪爱联合疗法,该疗法疗效确切,易于操作,治疗时间短,有利于患者早日恢复健康。
Objective To observe the clinical effect of oral Yinzhihuang combined with Mami＇ai to cure neonatal jaundice.Methods A total of 2014 November to 2015 November to our hospital to accept treatment of 180 cases of neonatal jaundice patients as the research object, according to the random will be divided into control group and observation group, the patients in the control group received conventional therapy, observation group under blue light irradiation, accept oral Yinzhihuang, Mami＇ai combined therapy. After treatment, compared with two groups of clinical effects and the duration of jaundice. Results Clinical effect： in the observation group, the total efficiency was 93.3%（84/90）. In the control group the total efficiency of 66.7%（60 / 90）. In the observation group, the total efficiency is higher than that of the control group（P〈0.05, χ^2=20.0）; observation group of jaundice duration for（4.6±1.0）d, significantly shorter than that of the control group（6.9±1.4）d, significant difference（P〈0.01, t=12.6）. Conclusion For neonatal jaundice, clinical should advocate choose oral Yinzhihuang and Medilac Vita combined therapy, the therapy is effective, easy operation, short treatment time, is conducive to the early recovery of patients.
出处
《系统医学》
2016年第3期50-52,58,共4页
Systems Medicine
关键词
茵栀黄
妈咪爱
新生儿黄疸
临床观察
Yinzhihuang
Mamiai
Neonatal jaundice
Clinical observation
